Amedeo Smart

Free Medical Literature Service


 

Amedeo

Venous Thrombosis

  Free Subscription

Articles published in
Thromb Res
    November 2021
  1. BOLZACCHINI E, Pomero F, Fazio M, Civitelli C, et al
    Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis.
    Thromb Res. 2021;208:190-197.
    >> Share

  2. ZUIN M, Cervellati C, Rigatelli G, Zuliani G, et al
    Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
    Thromb Res. 2021;208:170-172.
    >> Share

  3. GIRAUD M, Catella J, Cognet L, Helfer H, et al
    Management of acute venous thromboembolism in patients taking antiplatelet therapy.
    Thromb Res. 2021;208:156-161.
    >> Share

  4. GUPTA A, Chegondi M, Billa RD, Bloxham J, et al
    Validation of risk assessment models for venous thromboembolism and bleeding in critically ill adolescents.
    Thromb Res. 2021;208:106-111.
    >> Share

  5. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
    Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
    Thromb Res. 2021 Nov 3. pii: S0049-3848(21)00492.
    >> Share

    October 2021
  6. LEE A, Oley F Jr, Lo M, Fong R, et al
    Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors.
    Thromb Res. 2021;208:148-155.
    >> Share

  7. NAYAK AL, Zahrai A, Mallick R, Wang TF, et al
    Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial.
    Thromb Res. 2021;208:79-82.
    >> Share

  8. HILL H, Robinson M, Lu L, Slaughter D, et al
    Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapy.
    Thromb Res. 2021;208:71-78.
    >> Share

  9. HANSEN ES, Rinde FB, Edvardsen MS, Hindberg K, et al
    Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism.
    Thromb Res. 2021;208:121-126.
    >> Share

  10. LI A, Brandt W, Brown C, Wang TF, et al
    Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis.
    Thromb Res. 2021;208:58-65.
    >> Share

  11. HAZELTINE MD, Guber RD, Buettner H, Dorfman JD, et al
    Venous thromboembolism risk stratification in trauma using the Caprini risk assessment model.
    Thromb Res. 2021;208:52-57.
    >> Share

  12. LI J, Yi J, Hua L, Su Y, et al
    Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer.
    Thromb Res. 2021;208:45-51.
    >> Share

  13. BALLERIE A, Nguyen Van R, Lacut K, Galinat H, et al
    Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes.
    Thromb Res. 2021;208:39-44.
    >> Share

  14. DOUILLET D, Riou J, Penaloza A, Moumneh T, et al
    Risk of symptomatic venous thromboembolism in mild and moderate COVID-19: A comparison of two prospective European cohorts.
    Thromb Res. 2021;208:4-10.
    >> Share

  15. PASHA AK, McBane RD, Chaudhary R, Padrnos LJ, et al
    Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19.
    Thromb Res. 2021;207:150-157.
    >> Share

  16. BOON GJAM, Janssen SMJ, Barco S, Bogaard HJ, et al
    Efficacy and safety of a 12-week outpatient pulmonary rehabilitation program in Post-PE Syndrome.
    Thromb Res. 2021;206:66-75.
    >> Share

    September 2021
  17. TCHAIKOVSKI SN, Thomassen MCLGD, Stickeler E, Bremme K, et al
    Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolism.
    Thromb Res. 2021;207:143-149.
    >> Share

  18. LUU IHY, Kroon FPB, Buijs J, Krdzalic J, et al
    Systematic screening for pulmonary embolism using the YEARS algorithm in patients with suspected COVID-19 in the Emergency Department.
    Thromb Res. 2021;207:113-115.
    >> Share

  19. MARTIN AM, Polistena P, Mahmud A, Bettridge B, et al
    Optimal enoxaparin dosing strategies for venous thromboembolism prophylaxis and treatment of high body weight patients.
    Thromb Res. 2021;207:116-122.
    >> Share

  20. GABET A, Grave C, Tuppin P, Emmerich J, et al
    Changes in the epidemiology of patients hospitalized in France with deep venous thrombosis and pulmonary embolism during the COVID-19 pandemic.
    Thromb Res. 2021;207:67-74.
    >> Share

  21. OAKES M, Arastu A, Kato C, Somers J, et al
    Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone.
    Thromb Res. 2021;207:96-98.
    >> Share

    August 2021
  22. STESSEL B, Peeters J, Bruckers L, Nulens M, et al
    Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship?
    Thromb Res. 2021;206:139-141.
    >> Share

  23. HAKSTEEN WE, Hilderink BN, Dujardin RWG, Jansen RR, et al
    Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients.
    Thromb Res. 2021;206:128-130.
    >> Share

  24. YAMAURA G, Ito T, Miyaji Y, Ueda N, et al
    Therapeutic efficacy of heparin and direct factor Xa inhibitors in cancer-associated cryptogenic ischemic stroke with venous thromboembolism.
    Thromb Res. 2021;206:99-103.
    >> Share

  25. WENGER N, Sebastian T, Engelberger RP, Kucher N, et al
    Pulmonary embolism and deep vein thrombosis: Similar but different.
    Thromb Res. 2021;206:88-98.
    >> Share

  26. JOHNSON SA, Jones AE, Young E, Jennings C, et al
    A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study.
    Thromb Res. 2021;206:120-127.
    >> Share

  27. FERNANDO SM, Mathew R, Munshi L, Siegal DM, et al
    Media portrayals of pulmonary embolism.
    Thromb Res. 2021;206:52-54.
    >> Share

  28. FILIPPI L, Sartori M, Facci M, Trentin M, et al
    Pulmonary embolism in patients with COVID-19 pneumonia: When we have to search for it?
    Thromb Res. 2021;206:29-32.
    >> Share

  29. HANNA-SAWIRES RG, Groen JV, Hamming A, Tollenaar RAEM, et al
    Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer.
    Thromb Res. 2021;207:134-139.
    >> Share

  30. KNOLL W, Fergusson N, Ivankovic V, Wang TF, et al
    Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature.
    Thromb Res. 2021;204:114-122.
    >> Share

    July 2021
  31. HOLSTEEN P, Meier M, Brennan L, VanHorn T, et al
    Safety and effectiveness of a risk-stratified venous thromboembolism prophylaxis algorithm in young people with cystic fibrosis.
    Thromb Res. 2021;206:36-41.
    >> Share

  32. GRANOT Y, Rozenbaum Z, Ziv-Baran T, Fares R, et al
    Correlation between CT-derived cardiac chamber volume, myocardial injury and mortality in acute pulmonary embolism.
    Thromb Res. 2021;205:63-69.
    >> Share

  33. DANIELSBACKA JS, Rostberg L, Olsen MF, Mannerkorpi K, et al
    "Whole life changed" - Experiences of how symptoms derived from acute pulmonary embolism affects life. A qualitative interview study.
    Thromb Res. 2021;205:56-62.
    >> Share

  34. LACHANT D, Roto D, Rappaport S, Prasad P, et al
    Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza.
    Thromb Res. 2021;205:40-43.
    >> Share

  35. METRA B, Summer R, Brooks SE, George G, et al
    Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study.
    Thromb Res. 2021;205:84-91.
    >> Share

  36. GAWLITZA J, Ziegelmayer S, Wilkens H, Jagoda P, et al
    Beyond the d-dimer - Machine-learning assisted pre-test probability evaluation in patients with suspected pulmonary embolism and elevated d-dimers.
    Thromb Res. 2021;205:11-16.
    >> Share

  37. COHEN AT, Maraveyas A, Beyer-Westendorf J, Lee AYY, et al
    Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism - The COSIMO study.
    Thromb Res. 2021;206:1-4.
    >> Share

  38. RIGATELLI G, Zuin M
    Not all patent foramen ovales are alike!
    Thromb Res. 2021;203:81.
    >> Share

  39. SKILLE H, Paulsen B, Hveem K, Severinsen MT, et al
    Prothrombotic genotypes and risk of venous thromboembolism in occult cancer.
    Thromb Res. 2021;205:17-23.
    >> Share

    June 2021
  40. JIN MC, Sussman ES, Feng AY, Han SS, et al
    Hemorrhage risk of direct oral anticoagulants in real-world venous thromboembolism patients.
    Thromb Res. 2021;204:126-133.
    >> Share

  41. RIVERA-LEBRON B, Bauersachs R
    Direct oral anticoagulants for the treatment of pulmonary embolism in patients with renal impairment.
    Thromb Res. 2021;204:101-107.
    >> Share

  42. KO D, Preis SR, Johnson AD, Vasan RS, et al
    Relations of arterial stiffness and endothelial dysfunction with incident venous thromboembolism.
    Thromb Res. 2021;204:108-113.
    >> Share

  43. SANSILVESTRI-MOREL P, Rupin A, Schaffner AP, Bertin F, et al
    S62798, a potent TAFIa inhibitor, accelerates endogenous fibrinolysis in a murine model of pulmonary thromboembolism.
    Thromb Res. 2021;204:81-87.
    >> Share

  44. YAMASHITA Y, Bikdeli B, Monreal M, Morimoto T, et al
    Difference between Japanese and White patients with acute pulmonary embolism.
    Thromb Res. 2021;204:52-56.
    >> Share

  45. BAN L, Abdul Sultan A, West J, Tata LJ, et al
    External validation of a model to predict women most at risk of postpartum venous thromboembolism: Maternity clot risk.
    Thromb Res. 2021 Jun 8. pii: S0049-3848(21)00360.
    >> Share

  46. BLONDON M, Martinez de Tejada B, Glauser F, Righini M, et al
    Management of high-risk pulmonary embolism in pregnancy.
    Thromb Res. 2021;204:57-65.
    >> Share

  47. MENDONCA JC, Martins J, Fernandes C, Carvalho C, et al
    Cancer risk after a venous thrombotic event - RIETE score.
    Thromb Res. 2021;202:43-44.
    >> Share

  48. VALERIO L, Corsi G, Granziera S, Holm K, et al
    Sex differences in Lemierre syndrome: Individual patient-level analysis.
    Thromb Res. 2021;202:36-39.
    >> Share

    May 2021
  49. RAHBAR E, Cotton BA, Wade CE, Cardenas JC, et al
    Acquired antithrombin deficiency is a risk factor for venous thromboembolism after major trauma.
    Thromb Res. 2021;204:9-12.
    >> Share

  50. PAGENHARDT J, Hayward I, Dilcher B, Quedado K, et al
    Incidence of abnormal uterine bleeding in a multicenter implementation study using apixaban and rivaroxaban to treat venous thromboembolism.
    Thromb Res. 2021;204:29-31.
    >> Share

  51. LE MAO R, Tromeur C, Couturaud F
    A case of acute pulmonary embolism with severe haemoptysis.
    Thromb Res. 2021 May 18. pii: S0049-3848(21)00332.
    >> Share

  52. NOUMEGNI SR, Hoffmann C, Tromeur C, Lacut K, et al
    Frequency and incidence of arterial events in patients with venous thromboembolism compared to the general population: A systematic review and meta-analysis of cohort studies.
    Thromb Res. 2021;203:172-185.
    >> Share

  53. GOTO S, Turpie AGG, Farjat AE, Weitz JI, et al
    The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE.
    Thromb Res. 2021;203:155-162.
    >> Share

  54. BARATH B, Bogati R, Miklos T, Kallai J, et al
    Effect of alpha2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
    Thromb Res. 2021;203:110-116.
    >> Share

  55. ARRIBALZAGA K, Martinez-Alfonzo I, Diaz-Aizpun C, Gutierrez-Jomarron I, et al
    Incidence and clinical profile of venous thromboembolism in hospitalized COVID-19 patients from Madrid region.
    Thromb Res. 2021;203:93-100.
    >> Share

  56. JOHNSON SA, Signor EA, Lappe KL, Shi J, et al
    A comparison of natural language processing to ICD-10 codes for identification and characterization of pulmonary embolism.
    Thromb Res. 2021;203:190-195.
    >> Share

  57. MUMOLI N, Conte G, Cei M, Vitale J, et al
    In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis.
    Thromb Res. 2021;203:82-84.
    >> Share

  58. BAKKUM MJ, Schouten VL, Smulders YM, Nossent EJ, et al
    Accelerated treatment with rtPA for pulmonary embolism induced circulatory arrest.
    Thromb Res. 2021;203:74-80.
    >> Share

  59. HAMER HM, Stroobants AK, Bavalia R, Ponjee GAE, et al
    Diagnostic accuracy of four different D-dimer assays: A post-hoc analysis of the YEARS study.
    Thromb Res. 2021;201:18-22.
    >> Share

    April 2021
  60. BAUMANN KREUZIGER L, Gaddh M, Onadeko O, George G, et al
    Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.
    Thromb Res. 2021;202:155-161.
    >> Share

  61. KAPTEIN FHJ, Kroft LJM, Hammerschlag G, Ninaber MK, et al
    Pulmonary infarction in acute pulmonary embolism.
    Thromb Res. 2021;202:162-169.
    >> Share

  62. HUSSER D, Hohenstein S, Pellissier V, Konig S, et al
    Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic.
    Thromb Res. 2021;202:145-147.
    >> Share

    March 2021
  63. DOUROS A, Filliter C, Azoulay L, Tagalakis V, et al
    Effectiveness and safety of direct oral anticoagulants in patients with cancer associated venous thromboembolism.
    Thromb Res. 2021;202:128-133.
    >> Share

  64. YUAN S, Bruzelius M, Hakansson N, Akesson A, et al
    Lifestyle factors and venous thromboembolism in two cohort studies.
    Thromb Res. 2021;202:119-124.
    >> Share

  65. BRAILOVSKY Y, Masic D, Allen S, Lakhter V, et al
    Novel CT-derived parameter is associated with low cardiac index in acute pulmonary embolism.
    Thromb Res. 2021;202:105-107.
    >> Share

  66. SKEITH L, Le Gal G, Rodger MA
    Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?
    Thromb Res. 2021;202:134-138.
    >> Share

  67. KIRCHBERGER I, Berghaus TM, von Scheidt W, Linseisen J, et al
    COVID-19 risk perceptions, worries and preventive behaviors in patients with previous pulmonary embolism.
    Thromb Res. 2021;202:77-83.
    >> Share

  68. ALLEN S, Chan L, Masic D, Porcaro K, et al
    Comparison of outcomes in catheter-directed versus ultrasound-assisted thrombolysis for management of submassive pulmonary embolism.
    Thromb Res. 2021;202:96-99.
    >> Share

  69. PETRELLI F, Solinas C
    Reply to the letter to the editor 'Reply to Solinas et al, venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review' by Frere et al.
    Thromb Res. 2021 Mar 11. pii: S0049-3848(21)00092.
    >> Share

  70. AKTAA S, Wu J, Nadarajah R, Rashid M, et al
    Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.
    Thromb Res. 2021;202:17-23.
    >> Share

  71. LACUT K, Le Moigne E, Couturaud F, Font C, et al
    Outcomes in patients with acute pulmonary embolism and patent foramen ovale: Findings from the RIETE registry.
    Thromb Res. 2021;202:59-66.
    >> Share

  72. ARANDA C, Peralta L, Gagliardi L, Lopez A, et al
    A significant decrease in D-dimer concentration within one month of anticoagulation therapy as a predictor of both complete recanalization and risk of recurrence after initial pulmonary embolism.
    Thromb Res. 2021;202:31-35.
    >> Share

  73. FRERE C, Ederhy S, Salem JE
    Letter to the editors-in-chief reply to: Solinas et al. Venous and arterial thromboembolic events with immune check point inhibitors: A systematic review.
    Thromb Res. 2021 Mar 3. pii: S0049-3848(21)00083.
    >> Share

  74. WANG L, Wei S, Zhou B, Wu S, et al
    A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors.
    Thromb Res. 2021;202:52-58.
    >> Share

  75. KAPTEIN FHJ, Stals MAM, Grootenboers M, Braken SJE, et al
    Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave.
    Thromb Res. 2021;199:143-148.
    >> Share

  76. ESENWA C, Unda SR, Altschul DJ, Patel NK, et al
    The effect of race on composite thrombotic events in patients with COVID-19.
    Thromb Res. 2021;199:10-13.
    >> Share

    February 2021
  77. WHYTE MB, Barker R, Kelly PA, Gonzalez E, et al
    Three-month follow-up of pulmonary embolism in patients with COVID-19.
    Thromb Res. 2021;201:113-115.
    >> Share

  78. GARCIA-ORTEGA A, Lopez-Reyes R, Anguera G, Oscullo G, et al
    Venous thromboembolism in solid-organ transplant recipients: Findings from the RIETE registry.
    Thromb Res. 2021;201:131-138.
    >> Share

  79. ANGCHAISUKSIRI P, Goto S, Farjat AE, Fryk H, et al
    Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE.
    Thromb Res. 2021;201:63-72.
    >> Share

  80. JERVAN O, Gleditsch J, Tavoly M, Klok FA, et al
    Pulmonary and cardiac variables associated with persistent dyspnea after pulmonary embolism.
    Thromb Res. 2021;201:90-99.
    >> Share

  81. SKAJAA N, Nagy D, Schonfeldt Troelsen F, Kormendine Farkas D, et al
    Venous thromboembolism and risk of cancer in users of statins: A Danish population-based cohort study.
    Thromb Res. 2021;201:1-5.
    >> Share

  82. MCFARLANE SQ, Patel JP, Auyeung V, Arya R, et al
    An international survey of low molecular weight heparin prescribing in the context of antenatal venous thromboembolism.
    Thromb Res. 2021;200:99-101.
    >> Share


  83. Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study.
    Thromb Res. 2021;200:130-132.
    >> Share

    January 2021
  84. STEIN PD, Matta F, Hughes PG, Gerstner BJ, et al
    Usefulness of ancillary findings on CT pulmonary angiograms that are negative for pulmonary embolism.
    Thromb Res. 2021;200:48-50.
    >> Share

  85. BECATTINI C, Cimini LA, Carrier M
    Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding.
    Thromb Res. 2021;200:41-47.
    >> Share

  86. BOIETTI B, Fili S, Peuchot V, Tabares A, et al
    Impact of the use of rivaroxaban in the length of stay of patients treated for acute venous thromboembolism in a developing country.
    Thromb Res. 2021 Jan 26. pii: S0049-3848(21)00030.
    >> Share

  87. PETERSEN PB, Lindberg-Larsen M, Jorgensen CC, Kehlet H, et al
    Venous thromboembolism after fast-track elective revision hip and knee arthroplasty - A multicentre cohort study of 2814 unselected consecutive procedures.
    Thromb Res. 2021;199:101-105.
    >> Share

  88. GANGARAJU R, Gahagan A, Bhatia S, Kenzik K, et al
    Venous-thromboembolism in elderly patients with acute myeloid leukemia.
    Thromb Res. 2021;200:9-11.
    >> Share

  89. DESANCHO M, Munn JE, Billett HH, Cheng D, et al
    Transition of care for pediatric and adult patients with venous thromboembolism: A National Quality Improvement Project from the American Thrombosis and Hemostasis Network (ATHN).
    Thromb Res. 2021;200:23-29.
    >> Share

  90. DE WINTER MA, van Es N, Buller HR, Visseren FLJ, et al
    Prediction models for recurrence and bleeding in patients with venous thromboembolism: A systematic review and critical appraisal.
    Thromb Res. 2021;199:85-96.
    >> Share

  91. MURGIER M, Fouillet L, Ollier E, Merah A, et al
    Recovery from acute kidney injury in patients with pulmonary embolism: A single-center study.
    Thromb Res. 2021;199:106-109.
    >> Share

  92. SINDET-PEDERSEN C, Olesen JB, Blanche P, Gerds TA, et al
    Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study.
    Thromb Res. 2021;199:97-100.
    >> Share

  93. AYELE HT, Brunetti VC, Renoux C, Tagalakis V, et al
    Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials.
    Thromb Res. 2021;199:123-131.
    >> Share

  94. MOIK F, Makatsariya A, Ay C
    Challenging anticoagulation cases: Cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopenia - A case-based review of clinical management.
    Thromb Res. 2021;199:38-42.
    >> Share

  95. MANDAL AKJ, Kho J, Ioannou A, Van den Abbeele K, et al
    In situ immune-mediated pulmonary artery thrombosis and Covid-19 pneumonitis.
    Thromb Res. 2021;197:112-113.
    >> Share

  96. PANCANI R, Villari L, Foci V, Parri G, et al
    Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units.
    Thromb Res. 2021;197:44-47.
    >> Share

    December 2020
  97. ACHEBE I, Mbachi C, Palacios P, Wang Y, et al
    Predictors of venous thromboembolism in hospitalized patients with inflammatory bowel disease and colon cancer: A retrospective cohort study.
    Thromb Res. 2020;199:14-18.
    >> Share

  98. ALAM AU, Karkhaneh M, Sun HL, Wu C, et al
    Survival patterns among venous thromboembolism patients with hematologic malignancies in Alberta, Canada from 2003 to 2015.
    Thromb Res. 2020;199:59-66.
    >> Share

  99. NAUKA PC, Baron SW, Assa A, Mohrmann L, et al
    Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors.
    Thromb Res. 2020;199:82-84.
    >> Share

  100. VAN DAM LF, Kroft LJM, Boon GJAM, Huisman MV, et al
    Computed tomography pulmonary perfusion imaging and 3-months clinical outcomes after acute pulmonary embolism.
    Thromb Res. 2020;199:32-34.
    >> Share

  101. RASHIDI F, Barco S, Kamangar F, Heresi GA, et al
    Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study.
    Thromb Res. 2020;198:135-138.
    >> Share

  102. GUO JD, Hlavacek P, Rosenblatt L, Keshishian A, et al
    Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population.
    Thromb Res. 2020;198:163-170.
    >> Share

  103. DE WIT K, Linkins LA
    A case of acute pulmonary embolism in a patient with chronic thrombocytopenia.
    Thromb Res. 2020;198:83-85.
    >> Share

  104. MIAO R, Dong X, Gong J, Wang Y, et al
    Possible immune regulation mechanisms for the progression of chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2020;198:122-131.
    >> Share

  105. ALHOUSANI M, Malik SU, Abu-Hashyeh A, Poznanski NJ, et al
    Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2020;198:103-114.
    >> Share

  106. WANG L, Chen F, Bai L, Yi Q, et al
    In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist.
    Thromb Res. 2020;196:541-542.
    >> Share

  107. PARKS AL, Auerbach AD, Schnipper JL, Anstey JE, et al
    COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.
    Thromb Res. 2020;196:355-358.
    >> Share

    November 2020
  108. KANEDA K, Yamashita Y, Morimoto T, Amano H, et al
    Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry.
    Thromb Res. 2020;198:26-33.
    >> Share

  109. LI A, Eshaghpour A, Tseng EK, Douketis JD, et al
    Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more.
    Thromb Res. 2020;198:1-6.
    >> Share

  110. POLI D, Migliaccio L, Antonucci E, Biancone L, et al
    Venous thromboembolism in renal transplant recipients: Results of Venous thromboEmbolism in renal Transplant Recipients- Italian Study - VETRIS.
    Thromb Res. 2020;198:52-54.
    >> Share

  111. SCUDIERO F, Silverio A, Di Maio M, Russo V, et al
    Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome.
    Thromb Res. 2020;198:34-39.
    >> Share

  112. STEINBRECHER O, Sinkovec H, Eischer L, Kyrle PA, et al
    D-dimer levels over time after anticoagulation and the association with recurrent venous thromboembolism.
    Thromb Res. 2020;197:160-164.
    >> Share

  113. BUDD AC, Rhodes M, Forster AJ, Noghani P, et al
    Prescribing patterns and outcomes of venous thromboembolism prophylaxis in hospitalized medical and cancer patients: Observations from the Ottawa Hospital.
    Thromb Res. 2020;197:144-152.
    >> Share

  114. PLANQUETTE B, Le Berre A, Khider L, Yannoutsos A, et al
    Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study.
    Thromb Res. 2020;197:94-99.
    >> Share

  115. ROBERGE G, Delluc A
    Challenging anticoagulation cases: A case of incidental subsegmental pulmonary embolism in a patient with cancer.
    Thromb Res. 2020;197:77-83.
    >> Share

  116. ANDRADE I, Mehdipoor G, Le Mao R, Garcia-Sanchez A, et al
    Prognostic significance of computed tomography-assessed right ventricular enlargement in low-risk patients with pulmonary embolism: Systematic review and meta-analysis.
    Thromb Res. 2020;197:48-55.
    >> Share

  117. PAYNE JG, Tagalakis V, Wu C, Lazo-Langner A, et al
    Current estimates of the incidence of acute venous thromboembolic disease in Canada: A meta-analysis.
    Thromb Res. 2020;197:8-12.
    >> Share

  118. MARCHIORI E, Nobre LF, Hochhegger B, Zanetti G, et al
    The reversed halo sign: Considerations in the context of the COVID-19 pandemic.
    Thromb Res. 2020;195:228-230.
    >> Share

  119. ELIAS A, Schmidt J, Bellou A, Le Gal G, et al
    Opinion and practice survey about the use of prognostic models in acute pulmonary embolism.
    Thromb Res. 2020;198:40-48.
    >> Share

    October 2020
  120. SERRAO A, Ballotta L, Dragoni F, Pallotta A, et al
    Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants (DOACs) in patients with major congenital thrombophilia.
    Thromb Res. 2020;196:539-540.
    >> Share

  121. SPEED V, Patel JP, Roberts LN, Patel RK, et al
    UK real-world experience of prescribing rivaroxaban for acute venous thromboembolism in obesity: Results from the FIRST Registry.
    Thromb Res. 2020;197:16-19.
    >> Share

  122. BRUGGEMANN RAG, Spaetgens B, Gietema HA, Brouns SHA, et al
    The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison.
    Thromb Res. 2020;196:486-490.
    >> Share

  123. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
    Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
    Thromb Res. 2020 Oct 13. pii: S0049-3848(20)30537.
    >> Share

  124. VAN DAM LF, Kroft LJM, van der Wal LI, Cannegieter SC, et al
    More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism.
    Thromb Res. 2020;196:435-436.
    >> Share

  125. HAN X, Li C, Zhang S, Hou X, et al
    Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies.
    Thromb Res. 2020;196:500-509.
    >> Share

  126. VALERIO L, Corsi G, Sebastian T, Barco S, et al
    Lemierre syndrome: Current evidence and rationale of the Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry.
    Thromb Res. 2020;196:494-499.
    >> Share

  127. CHOPARD R, Badoz M, Eveno C, Ecarnot F, et al
    Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study.
    Thromb Res. 2020;196:476-482.
    >> Share

  128. GERSTEIN L, Koolian M, Schwartz BC
    Sub-segmental pulmonary emboli as a marker of CT-pulmonary angiogram overuse in a single-center retrospective cohort study: A dimer a dozen?
    Thromb Res. 2020;196:463-465.
    >> Share

  129. DOYLE AJ, Thomas W, Retter A, Besser M, et al
    Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units.
    Thromb Res. 2020;196:454-456.
    >> Share

  130. SOLINAS C, Saba L, Sganzerla P, Petrelli F, et al
    Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review.
    Thromb Res. 2020;196:444-453.
    >> Share

  131. RASMUSSEN PV, Blanche P, Strange JE, Butt JH, et al
    Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark.
    Thromb Res. 2020;194:220-221.
    >> Share

    September 2020
  132. YANG M, Qi J, Tang Y, Wu D, et al
    Increased D-dimer predicts the risk of cancer-associated recurrent venous thromboembolism and venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2020;196:410-413.
    >> Share

  133. MA SG, Hu J, Huang Y
    The risk factors for perioperative venous thromboembolism in patients with gynecological malignancies: A meta-analysis.
    Thromb Res. 2020;196:325-334.
    >> Share

  134. CHOI JJ, Wehmeyer GT, Li HA, Alshak MN, et al
    D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19.
    Thromb Res. 2020;196:318-321.
    >> Share

  135. CASTELLON RUBIO VE, Segura PP, Munoz A, Farre AL, et al
    High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
    Thromb Res. 2020;196:349-354.
    >> Share

  136. DUJARDIN RWG, Hilderink BN, Haksteen WE, Middeldorp S, et al
    Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Thromb Res. 2020;196:308-312.
    >> Share

  137. ROLVING N, Bloch-Nielsen JR, Brocki BC, Andreasen J, et al
    Perspectives of patients and health professionals on important factors influencing rehabilitation following acute pulmonary embolism: A multi-method study.
    Thromb Res. 2020;196:283-290.
    >> Share

  138. PAVONI V, Gianesello L, Pazzi M, Stera C, et al
    Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
    Thromb Res. 2020;196:313-317.
    >> Share

  139. AGNELLI G, Hoffmann U, Hainaut P, Gaine S, et al
    ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months.
    Thromb Res. 2020;196:297-304.
    >> Share

  140. DELATE T, Charlu M, Zhu S, Pai A, et al
    Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolism.
    Thromb Res. 2020;196:367-370.
    >> Share

  141. MIRO O, Llorens P, Aguirre A, Lozano L, et al
    Association between Covid-19 and Pulmonary Embolism (AC-19-PE study).
    Thromb Res. 2020;196:322-324.
    >> Share

  142. PIZZI R, Gini G, Caiano L, Castelli B, et al
    Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency.
    Thromb Res. 2020;196:209-212.
    >> Share

  143. RAJENDRAM R, Kharal GA, Mahmood N, Kharal M, et al
    Systemic thromboemboli in patients with Covid-19 may result from paradoxical embolization.
    Thromb Res. 2020;196:206-208.
    >> Share

    August 2020
  144. HANNEVIK TL, Brekke J, Enden T, Froen H, et al
    Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism.
    Thromb Res. 2020;196:238-244.
    >> Share

  145. BEENEN LFM, Bos LD, Scheerder MJ, Lobe NHJ, et al
    Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia.
    Thromb Res. 2020;196:135-137.
    >> Share

  146. ZERMATTEN MG, Pantet O, Gomez F, Schneider A, et al
    Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19.
    Thromb Res. 2020;196:222-226.
    >> Share

  147. SCHAEFER JK, Henke PK, Barnes GD
    Managing suspected venous thromboembolism when a pandemic limits diagnostic testing.
    Thromb Res. 2020;196:213-214.
    >> Share

  148. COELHO J, Divernet-Queriaud M, Roy PM, Penaloza A, et al
    Comparison of the Wells score and the revised Geneva score as a tool to predict pulmonary embolism in outpatients over age 65.
    Thromb Res. 2020;196:120-126.
    >> Share

  149. JARVIS KB, Nielsen RL, Gupta R, Hede FD, et al
    Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia.
    Thromb Res. 2020;196:15-20.
    >> Share

  150. PORFIDIA A, Valeriani E, Pola R, Porreca E, et al
    Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis.
    Thromb Res. 2020;196:67-74.
    >> Share

  151. KUNUTSOR SK, Laukkanen JA
    Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis.
    Thromb Res. 2020;196:27-30.
    >> Share

  152. FRIBERG L, Svennberg E
    A diagnosis of atrial fibrillation is not a predictor for pulmonary embolism.
    Thromb Res. 2020;195:238-242.
    >> Share

  153. NOJIMA J, Kaneshige R, Motoki Y, Ieko M, et al
    Increased oxidative stress may be a risk factor for thromboembolic complications in patients with antiphospholipid syndrome.
    Thromb Res. 2020;196:52-53.
    >> Share

  154. TSOLAKI V, Zakynthinos GE, Mantzarlis K
    Right ventricular dilation: The additive effect of mechanical ventilation on pulmonary embolism in Covid-19 patients.
    Thromb Res. 2020;196:25-26.
    >> Share

    July 2020
  155. KOVACS MR, Lazo-Langner A, Louzada ML, Kovacs MJ, et al
    Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolism.
    Thromb Res. 2020;195:231-232.
    >> Share

  156. HASSAN S, Fanola C, Beckman A, Li F, et al
    Adult Langerhans histiocytosis with rare BRAF mutation complicated by massive pulmonary embolism.
    Thromb Res. 2020;193:207-210.
    >> Share

  157. ALBERTSEN IE, Nielsen PB
    How to optimize the value of administrative venous thromboembolism codes.
    Thromb Res. 2020;194:195-196.
    >> Share

  158. NITHIANANDAN H, Reilly A, Tritschler T, Wells P, et al
    Applying rigorous eligibility criteria to studies evaluating prognostic utility of serum biomarkers in pulmonary embolism: A systematic review and meta-analysis.
    Thromb Res. 2020;195:195-208.
    >> Share

  159. ZUIN M, Barco S, Zuliani G, Roncon L, et al
    Management of high-risk pulmonary embolism in an "unstable medical environment": Not only a matter of hemodynamic.
    Thromb Res. 2020;195:193-194.
    >> Share

  160. TRIMAILLE A, Curtiaud A, Marchandot B, Matsushita K, et al
    Venous thromboembolism in non-critically ill patients with COVID-19 infection.
    Thromb Res. 2020;193:166-169.
    >> Share

  161. PIAZZA G
    A fortune teller's dream or clinician's nightmare: Right ventricular assessment for risk prediction in pulmonary embolism.
    Thromb Res. 2020;195:169-170.
    >> Share

  162. EICHINGER S, Lin M, Shi M, Grosso MA, et al
    Recurrent venous thromboembolism during anticoagulation with edoxaban or warfarin: A post hoc analysis of the Hokusai-VTE trial.
    Thromb Res. 2020;195:209-214.
    >> Share

  163. LECUMBERRI R, Ruiz-Artacho P, Trujillo-Santos J, Brenner B, et al
    Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia.
    Thromb Res. 2020;195:139-145.
    >> Share

  164. WHYTE MB, Kelly PA, Gonzalez E, Arya R, et al
    Pulmonary embolism in hospitalised patients with COVID-19.
    Thromb Res. 2020;195:95-99.
    >> Share

  165. GHANIMA W, Brodin E, Schultze A, Shepherd L, et al
    Incidence and prevalence of venous thromboembolism in Norway 2010-2017.
    Thromb Res. 2020;195:165-168.
    >> Share

  166. ANDREW L, Ni Ainle F, Blondon M, Rodger MA, et al
    Preventing postpartum venous thromboembolism: A call to action to reduce undue maternal morbidity and mortality.
    Thromb Res. 2020;193:190-197.
    >> Share

  167. PETERSEN PB, Jorgensen CC, Gromov K, Kehlet H, et al
    Venous thromboembolism after fast-track unicompartmental knee arthroplasty - A prospective multicentre cohort study of 3927 procedures.
    Thromb Res. 2020;195:81-86.
    >> Share

  168. SCHWAB-DAUGHERTY EM, Peng MR, Caraccio EE, Stevens SM, et al
    Timing of parenteral anticoagulation after thrombolysis for the treatment of pulmonary embolism.
    Thromb Res. 2020;195:58-61.
    >> Share

  169. YURIDITSKY E, Mitchell OJL, Sista AK, Xia Y, et al
    Right ventricular stroke distance predicts death and clinical deterioration in patients with pulmonary embolism.
    Thromb Res. 2020;195:29-34.
    >> Share

  170. KLOK FA, Kruip MJHA, van der Meer NJM, Arbous MS, et al
    Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.
    Thromb Res. 2020;191:148-150.
    >> Share

  171. KLOK FA, Kruip MJHA, van der Meer NJM, Arbous MS, et al
    Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
    Thromb Res. 2020;191:145-147.
    >> Share

  172. MARAVEYAS A
    Latest advances in preventing thromboembolic disease in the ambulatory oncology patient.
    Thromb Res. 2020;191 Suppl 1:S91-S98.
    >> Share

  173. SANFILIPPO KM
    Assessing the risk of venous thromboembolism in multiple myeloma.
    Thromb Res. 2020;191 Suppl 1:S74-S78.
    >> Share

  174. GEROTZIAFAS GT, Mahe I, Lefkou E, AboElnazar E, et al
    Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer.
    Thromb Res. 2020;191 Suppl 1:S50-S57.
    >> Share

  175. ILICH A, Kumar V, Henderson M, Mallick R, et al
    Biomarkers in cancer patients at risk for venous thromboembolism: data from the AVERT study.
    Thromb Res. 2020;191 Suppl 1:S31-S36.
    >> Share

  176. NOBLE S
    Venous thromboembolism in palliative care patients: what do we know?
    Thromb Res. 2020;191 Suppl 1:S128-S132.
    >> Share

  177. VERSO M, Agnelli G
    Treatment of venous thromboembolism in patients with cancer: from clinical trials to real life.
    Thromb Res. 2020;191 Suppl 1:S123-S127.
    >> Share

    June 2020
  178. PREVITALI G, Seghezzi M, Moioli V, Sonzogni A, et al
    The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome?
    Thromb Res. 2020;194:192-194.
    >> Share

  179. NICHETTI F, Russo GL, Prelaj A, Provenzano L, et al
    ALK/ROS1 rearrangements: A real hallmark for thromboembolic events in cancer patients?
    Thromb Res. 2020;194:176-177.
    >> Share

  180. ZHANG GC, Zhang YY, Zeng QZ, Meng XY, et al
    Outcomes of symptomatic venous thromboembolism after haploidentical donor hematopoietic stem cell transplantation and comparison with human leukocyte antigen-identical sibling transplantation.
    Thromb Res. 2020;194:168-175.
    >> Share

  181. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
    Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism.
    Thromb Res. 2020;193:160-165.
    >> Share

  182. ROBIN P, van Es N, Le Roux PY, Rondina M, et al
    Performance of (18)F-fluorodesoxyglucose positron-emission tomography/computed tomography for cancer screening in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis.
    Thromb Res. 2020;194:153-157.
    >> Share

  183. MAKHOUL T, Kelly G, Kersten B, Nadler M, et al
    Incidence of thromboembolic events following administration of four-factor prothrombin complex concentrate (4F-PCC) for oral anticoagulation reversal.
    Thromb Res. 2020;194:158-164.
    >> Share

  184. OVERSTAD S, Tjonnfjord E, Garabet L, Fronas S, et al
    Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases.
    Thromb Res. 2020;194:116-118.
    >> Share

  185. HAYKAL T, Zayed Y, Deliwala S, Kerbage J, et al
    Direct oral anticoagulant versus low-molecular-weight heparin for treatment of venous thromboembolism in cancer patients: An updated meta-analysis of randomized controlled trials.
    Thromb Res. 2020;194:57-65.
    >> Share

  186. DEL-TORO-CERVERA J, Demelo-Rodriguez P, Galeano-Valle F, Fidalgo A, et al
    Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in patients with venous thromboembolism treated with vitamin K antagonists: Findings from the RIETE registry.
    Thromb Res. 2020;194:178-182.
    >> Share

  187. VAN DAM LF, Kroft LJM, van der Wal LI, Cannegieter SC, et al
    Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease?
    Thromb Res. 2020;193:86-89.
    >> Share

  188. MURTHY SK, Robertson McCurdy AB, Carrier M, McCurdy JD, et al
    Venous thromboembolic events in inflammatory bowel diseases: A review of current evidence and guidance on risk in the post-hospitalization setting.
    Thromb Res. 2020;194:26-32.
    >> Share

  189. PICART G, Robin P, Tromeur C, Orione C, et al
    Predictors of residual pulmonary vascular obstruction after pulmonary embolism: Results from a prospective cohort study.
    Thromb Res. 2020;194:1-7.
    >> Share

  190. IBRAHIM-KOSTA M, Bailly P, Silvy M, Saut N, et al
    ABO blood group, glycosyltransferase activity and risk of venous thromboembolism.
    Thromb Res. 2020;193:31-35.
    >> Share

  191. VELASCO D, Jimenez D, Bikdeli B, Muriel A, et al
    Outcome of patients with acute symptomatic pulmonary embolism and psychiatric disorders.
    Thromb Res. 2020;193:90-97.
    >> Share

    May 2020
  192. HENDRIKS SV, Bavalia R, van Bemmel T, Bistervels IM, et al
    Current practice patterns of outpatient management of acute pulmonary embolism: A post-hoc analysis of the YEARS study.
    Thromb Res. 2020;193:60-65.
    >> Share

  193. DESBOROUGH MJR, Doyle AJ, Griffiths A, Retter A, et al
    Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom.
    Thromb Res. 2020;193:1-4.
    >> Share

  194. PACKARD A, Delate T, Martinez K, Clark NP, et al
    Adherence to and persistence with direct oral anticoagulant therapy among patients with new onset venous thromboembolism receiving extended anticoagulant therapy and followed by a centralized anticoagulation service.
    Thromb Res. 2020;193:40-44.
    >> Share

  195. CHEN X, Shao X, Zhang Y, Zhang Z, et al
    Assessment of the Bova score for risk stratification of acute normotensive pulmonary embolism: A systematic review and meta-analysis.
    Thromb Res. 2020;193:99-106.
    >> Share

  196. KONIECZYNSKA M, Kupis RW, Bijak P, Malinowski KP, et al
    Acceptance of a potential major bleeding among patients with venous thromboembolism on long-term oral anticoagulation: the knowledge of the disease and therapy matters.
    Thromb Res. 2020;193:116-121.
    >> Share

  197. AKEL T, Qaqa F, Abuarqoub A, Shamoon F, et al
    Pulmonary embolism: A complication of COVID 19 infection.
    Thromb Res. 2020;193:79-82.
    >> Share

  198. PARRY AH, Wani AH
    Pulmonary embolism in coronavirus disease-19 (COVID-19) and use of compression ultrasonography in its optimal management.
    Thromb Res. 2020 May 16. pii: S0049-3848(20)30194.
    >> Share

  199. GALEANO-VALLE F, Oblitas CM, Ferreiro-Mazon MM, Alonso-Munoz J, et al
    Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism.
    Thromb Res. 2020 May 15. pii: S0049-3848(20)30189.
    >> Share

  200. RAHMANI J, Haghighian Roudsari A, Bawadi H, Thompson J, et al
    Relationship between body mass index, risk of venous thromboembolism and pulmonary embolism: A systematic review and dose-response meta-analysis of cohort studies among four million participants.
    Thromb Res. 2020;192:64-72.
    >> Share

  201. ROSEN RJ
    Early thromboembolic events in hospitalized COVID-19 patients.
    Thromb Res. 2020;192:1.
    >> Share

  202. VITALI C, Minniti A, Caporali R, Del Papa N, et al
    Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19.
    Thromb Res. 2020;192:21-22.
    >> Share

  203. NISHIMOTO Y, Yamashita Y, Morimoto T, Saga S, et al
    Predictive ability of modified Ottawa score for recurrence in patients with cancer-associated venous thromboembolism: From the COMMAND VTE Registry.
    Thromb Res. 2020;191:66-75.
    >> Share

  204. BRUGGEMANN R, Gietema H, Jallah B, Ten Cate H, et al
    Arterial and venous thromboembolic disease in a patient with COVID-19: A case report.
    Thromb Res. 2020 May 1. pii: S0049-3848(20)30163.
    >> Share

    April 2020
  205. BOUNAMEAUX H, Haas S, Farjat AE, Ageno W, et al
    Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE.
    Thromb Res. 2020;191:103-112.
    >> Share

  206. LODIGIANI C, Iapichino G, Carenzo L, Cecconi M, et al
    Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.
    Thromb Res. 2020;191:9-14.
    >> Share

  207. ELLIS-KAHANA J, Sparks AD, Gimovsky AC, James AH, et al
    Developing a model for predicting venous thromboembolism in obese pregnant women in a national study.
    Thromb Res. 2020;191:42-49.
    >> Share

  208. JOHNSEN HS, Bjori E, Hindberg K, Braekkan SK, et al
    Prothrombotic genotypes and risk of major bleeding in patients with incident venous thromboembolism.
    Thromb Res. 2020;191:82-89.
    >> Share

  209. RONCON L, Zuin M, Zonzin P
    Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients.
    Thromb Res. 2020;190:102.
    >> Share

  210. MARTINELLI I, Ferrazzi E, Ciavarella A, Erra R, et al
    Pulmonary embolism in a young pregnant woman with COVID-19.
    Thromb Res. 2020;191:36-37.
    >> Share

  211. FANG Q, Du W, Zhang X, Chen D, et al
    Venous thromboembolism and postoperative bleeding in thyroid surgery patients.
    Thromb Res. 2020;190:99-101.
    >> Share

  212. ROTZINGER DC, Beigelman-Aubry C, von Garnier C, Qanadli SD, et al
    Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography.
    Thromb Res. 2020;190:58-59.
    >> Share

    March 2020
  213. BOON GJAM, Barco S, Bertoletti L, Ghanima W, et al
    Measuring functional limitations after venous thromboembolism: Optimization of the Post-VTE Functional Status (PVFS) Scale.
    Thromb Res. 2020;190:45-51.
    >> Share

  214. KELLER K, Hobohm L, Barco S, Schmidtmann I, et al
    Venous thromboembolism in patients hospitalized for hip joint replacement surgery.
    Thromb Res. 2020;190:1-7.
    >> Share

  215. CHOI SH, Cha SI, Park JE, Park S, et al
    Electrocardiographic changes as a prognostic tool for hospitalized patients with pulmonary embolism.
    Thromb Res. 2020;192:61-63.
    >> Share

  216. RENZI M, Stafoggia M, Michelozzi P, Davoli M, et al
    Short-term exposure to PM2.5 and risk of venous thromboembolism: A case-crossover study.
    Thromb Res. 2020;190:52-57.
    >> Share

  217. MULDER FI, van Es N, Kraaijpoel N, Di Nisio M, et al
    Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19].
    Thromb Res. 2020 Mar 6. pii: S0049-3848(20)30069.
    >> Share

  218. HASAN RA, Koh AY, Zia A
    The gut microbiome and thromboembolism.
    Thromb Res. 2020;189:77-87.
    >> Share

  219. BAUMGARTNER C, Go AS, Fan D, Sung SH, et al
    Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.
    Thromb Res. 2020;189:112-118.
    >> Share

  220. LIANG S, Tang W, Ye S, Xiang L, et al
    Incidence and risk factors of preoperative venous thromboembolism and pulmonary embolism in patients with ovarian cancer.
    Thromb Res. 2020;190:129-134.
    >> Share

    February 2020
  221. DEGUCHI TK, Deguchi H, Guo Z, Elias DJ, et al
    Plasma skeletal muscle myosin phenotypes identified by immunoblotting are associated with pulmonary embolism occurrence in young adults.
    Thromb Res. 2020;189:88-92.
    >> Share

  222. KUNUTSOR SK, Barrett MC, Whitehouse MR, Blom AW, et al
    Venous thromboembolism following 672,495 primary total shoulder and elbow replacements: Meta-analyses of incidence, temporal trends and potential risk factors.
    Thromb Res. 2020;189:13-23.
    >> Share

  223. BAVIERA M, Barcella L, Vannini T, Colacioppo P, et al
    Treatment of venous thromboembolism in Northern Italy: A population-based study from 2013 to 2018.
    Thromb Res. 2020;188:97-99.
    >> Share

  224. DANIELSBACKA JS, Hansson PO, Mannerkorpi K, Olsen MF, et al
    Physical activity and respiratory symptoms after pulmonary embolism. A longitudinal observational study.
    Thromb Res. 2020;189:55-60.
    >> Share

  225. FULCHER J, Carrier M
    Thromboembolism prophylaxis during L-asparaginase therapy in acute lymphoblastic leukemia - time to reconsider current approaches?
    Thromb Res. 2020;188:100-102.
    >> Share

  226. SCHMIDT RA, Al Zaki A, Desilet N, Szefer E, et al
    Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism.
    Thromb Res. 2020;188:106-114.
    >> Share

    January 2020
  227. ROBIN P, Grewal RK, Le Roux PY, Le Gal G, et al
    Interobserver agreement of (18)F-Fluorodeoxyglucose Positron-Emission Tomography combined with low-dose Computed Tomography for occult cancer screening in patients with unprovoked venous thromboembolism.
    Thromb Res. 2020;188:25-27.
    >> Share

  228. VAN ES J, Cheung YW, van Es N, Klok FA, et al
    Short-term prognosis of breakthrough venous thromboembolism in anticoagulated patients.
    Thromb Res. 2020;187:125-130.
    >> Share

  229. CALAIS C, Mercier G, Meusy A, Le Collen L, et al
    Pulmonary embolism home treatment: What GP want?
    Thromb Res. 2020;187:180-185.
    >> Share

  230. QUAN S, Smith J, Wu C, Koshman SL, et al
    Anticoagulant therapies and outcomes in obese patients with acute venous thromboembolism.
    Thromb Res. 2020;187:56-62.
    >> Share

  231. TSUYUKI Y, Yamashita Y, Morimoto T, Amano H, et al
    Renal dysfunction and long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE Registry.
    Thromb Res. 2020;187:39-47.
    >> Share

  232. GARVEY S, Dudzinski DM, Giordano N, Torrey J, et al
    Pulmonary embolism with clot in transit: An analysis of risk factors and outcomes.
    Thromb Res. 2020;187:139-147.
    >> Share

    December 2019
  233. BIKDELI B, Wang Y, Jimenez D, Ross JS, et al
    Recent trends in use of inferior vena caval filters in US older adults with acute pulmonary embolism.
    Thromb Res. 2019;186:78-79.
    >> Share

  234. DOU F, Zhang Y, Yi J, Zhu M, et al
    Association of ALK rearrangement and risk of venous thromboembolism in patients with non-small cell lung cancer: A prospective cohort study.
    Thromb Res. 2019;186:36-41.
    >> Share

  235. DZIKOWSKA-DIDUCH O, Kostrubiec M, Kurnicka K, Lichodziejewska B, et al
    "The post-pulmonary syndrome - results of echocardiographic driven follow up after acute pulmonary embolism".
    Thromb Res. 2019;186:30-35.
    >> Share

  236. FRENETTE A, Gershkovich B, Castellucci LA, Patel RV, et al
    Venous thromboembolism prophylaxis in obese, critically-ill patients: A survey of Ottawa region Intensivists.
    Thromb Res. 2019;186:42-44.
    >> Share

    November 2019
  237. MEDEIROS SK, Emery B, Bhagirath V, Parpia S, et al
    Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism?
    Thromb Res. 2019;186:13-19.
    >> Share

  238. CANTOR N, Carrier M, Rodger MA, Veillet-Lemay G, et al
    Predictors of long-term cancer diagnosis after an unprovoked thromboembolic event: A post-hoc analysis of the REVERSE cohort study.
    Thromb Res. 2019;185:132-134.
    >> Share

  239. GARIANI K, Hugon-Rodin J, Philippe J, Righini M, et al
    Association between polycystic ovary syndrome and venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2019;185:102-108.
    >> Share

  240. BIKDELI B, Carrier MA, Bates SM
    Subsegmental pulmonary embolism: May not be a killer but indicates significant risk.
    Thromb Res. 2019 Nov 19. pii: S0049-3848(19)30504.
    >> Share

  241. TRUGILHO IA, Renni MJP, Medeiros GC, Thuler LCS, et al
    Incidence and factors associated with venous thromboembolism in women with gynecologic cancer.
    Thromb Res. 2019;185:49-54.
    >> Share

  242. SIMONA A, Limacher A, Mean M, Golaz O, et al
    High-sensitive cardiac troponin T as a marker of hemorrhagic complications in elderly patients anticoagulated for non-massive pulmonary embolism.
    Thromb Res. 2019;185:5-12.
    >> Share

  243. MULDER FI, van Es N, Kraaijpoel N, Di Nisio M, et al
    Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study.
    Thromb Res. 2019;185:13-19.
    >> Share

  244. JARVIS KB, LeBlanc M, Tulstrup M, Nielsen RL, et al
    Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study.
    Thromb Res. 2019;184:92-98.
    >> Share

  245. SKAJAA N, Szepligeti SK, Horvath-Puho E, Ghanima W, et al
    Initiation of statins and risk of venous thromboembolism: Population-based matched cohort study.
    Thromb Res. 2019;184:99-104.
    >> Share

  246. HENDRIKS SV, Huisman MV, Eikenboom JCJ, Fogteloo J, et al
    Home treatment of patients with cancer-associated venous thromboembolism - An evaluation of daily practice.
    Thromb Res. 2019;184:122-128.
    >> Share

  247. YAMASHITA Y, Murata K, Morimoto T, Amano H, et al
    Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE Registry.
    Thromb Res. 2019;184:50-57.
    >> Share

    October 2019
  248. KRIEG VJ, Hobohm L, Liebetrau C, Guth S, et al
    Risk factors for chronic thromboembolic pulmonary hypertension - Importance of thyroid disease and function.
    Thromb Res. 2019;185:20-26.
    >> Share

  249. BONNEFOY PB, Margelidon-Cozzolino V, Catella-Chatron J, Ayoub E, et al
    What's next after the clot? Residual pulmonary vascular obstruction after pulmonary embolism: From imaging finding to clinical consequences.
    Thromb Res. 2019;184:67-76.
    >> Share

  250. STOLLER N, Limacher A, Mean M, Baumgartner C, et al
    Clinical presentation and outcomes in elderly patients with symptomatic isolated subsegmental pulmonary embolism.
    Thromb Res. 2019;184:24-30.
    >> Share

  251. HEENKENDA MK, Malmstrom A, Lysiak M, Mudaisi M, et al
    Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma - The predictive significance of B blood group.
    Thromb Res. 2019;183:136-142.
    >> Share

  252. DE WINTER MA, Remme GCP, Kaasjager KHAH, Nijkeuter M, et al
    Short-term versus extended anticoagulant treatment for unprovoked venous thromboembolism: A survey on guideline adherence and physicians' considerations.
    Thromb Res. 2019;183:49-55.
    >> Share

  253. YU J, Li A, Laureano M, Crowther M, et al
    Frequency of arterial thromboembolism in populations with malignancies: A systematic review.
    Thromb Res. 2019;184:16-23.
    >> Share

  254. BYUN JM, Hong J, Yoon SS, Koh Y, et al
    Incidence and characteristics of venous thromboembolism in Asian patients with primary central nervous system lymphoma undergoing chemotherapy.
    Thromb Res. 2019;183:131-135.
    >> Share

    August 2019
  255. RAJPURKAR M, Williams S, Goldenberg NA, Van Ommen CH, et al
    Results of a multinational survey of diagnostic and management practices of thromboembolic pulmonary embolism in children.
    Thromb Res. 2019;183:98-105.
    >> Share

    May 2019
  256. GILLESPIE C, Foley S, Rowan M, Ewins K, et al
    The OPTICA study (Optimised Computed Tomography Pulmonary Angiography in Pregnancy Quality and Safety study): Rationale and design of a prospective trial assessing the quality and safety of an optimised CTPA protocol in pregnancy.
    Thromb Res. 2019;177:172-179.
    >> Share

  257. YAMASHITA Y, Morimoto T, Amano H, Takase T, et al
    Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry.
    Thromb Res. 2019;177:1-9.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016